STREAMEX CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
STREAMEX CORP. (STEX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $7.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-08-14
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-06-30 was -$111.22M, a 10832.46% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2026-03-31 was $111.23M, a 280205.93% increase year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-12-31 was $338.99K, a 665.69% increase year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $1.42M, a 102.10% increase from fiscal 2024.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $700.13K, a 51.58% decline from fiscal 2023.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $1.45M, a 20.96% decline from fiscal 2022.
- STREAMEX CORP. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $1.83M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$111.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $7.00K 10-Q · filed 2026-08-14 | $345.99K derived: sum of 3 quarters · filed 2026-08-14 | $345.99K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $111.23M 10-Q · filed 2026-05-14 | $111.57M derived: sum of 2 quarters · filed 2026-05-14 | $111.57M derived: sum of 3 quarters · filed 2026-05-14 | $112.61M derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | $338.99K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $338.99K derived: sum of 2 quarters · filed 2026-03-31 | $1.38M derived: sum of 3 quarters · filed 2026-03-31 | $1.42M 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-14 | $1.04M derived: sum of 2 quarters · filed 2025-11-14 | $1.08M 10-Q · filed 2025-11-14 | $1.12M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | $1.04M 10-Q · filed 2025-08-15 | $1.08M 10-Q · filed 2025-08-15 | $1.12M derived: sum of 3 quarters · filed 2025-08-15 | $1.62M derived: sum of 4 quarters · filed 2025-08-15 |
| 2025-03-31 | $39.68K 10-Q · filed 2025-05-19 | $83.95K derived: sum of 2 quarters · filed 2025-05-19 | $582.40K derived: sum of 3 quarters · filed 2025-05-19 | |
| 2024-12-31 | $44.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $542.72K derived: sum of 2 quarters · filed 2025-04-15 | $700.13K 10-K · filed 2025-04-15 | |
| 2024-09-30 | $498.44K 10-Q · filed 2024-11-14 | $655.86K 10-Q · filed 2024-11-14 | ||
| 2024-03-31 | $2.68K 10-Q · filed 2025-05-19 | $306.41K derived: sum of 2 quarters · filed 2025-05-19 | $809.07K derived: sum of 3 quarters · filed 2025-05-19 | $1.20M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $303.73K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $806.39K derived: sum of 2 quarters · filed 2025-04-15 | $1.19M derived: sum of 3 quarters · filed 2025-04-15 | $1.45M 10-K · filed 2025-04-15 |
| 2023-09-30 | $502.66K 10-Q · filed 2024-11-14 | $889.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.14M 10-Q · filed 2024-11-14 | $1.55M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $386.34K 10-Q · filed 2024-08-14 | $639.52K 10-Q · filed 2024-08-14 | $1.05M derived: sum of 3 quarters · filed 2024-08-14 | $1.47M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $257.19K 10-Q · filed 2024-05-20 | $663.13K derived: sum of 2 quarters · filed 2024-05-20 | $1.08M derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | $405.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $822.85K derived: sum of 2 quarters · filed 2024-04-16 | $1.83M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $416.91K 10-Q · filed 2023-11-14 | $1.42M 10-Q · filed 2023-11-14 | ||
| 2019-09-30 | $354.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $854.42K 10-Q · filed 2019-10-23 | ||
| 2019-06-30 | $499.44K 10-Q · filed 2019-07-31 | |||
| 2018-09-30 | $160.09K 10-Q · filed 2019-10-23 | $1.33M derived: sum of 2 quarters · filed 2019-10-23 | $1.57M 10-Q · filed 2019-10-23 | |
| 2018-06-30 | $1.17M 10-Q · filed 2019-07-31 | $1.41M 10-Q · filed 2019-07-31 | ||
| 2017-03-31 | $42.98K 10-Q · filed 2018-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B |